Neuron-Specific
Enolase (NSE) is recognized as a biomarker for small cell lung cancer. It is
secreted from neuroendocrine cells as well as neurogenic tumors. Its levels in
NSE-secreting neoplasms correlate with tumor mass and tumor metabolic activity. |
| Specificity |
Human
NSE |
| Production |
Cultured
in vitro under conditions free from
animal-derived components |
| Purification |
Protein
A/G affinity column |
| Formulation |
50
mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% Proclin 300 |
| Clone ID |
19A1 |
| Target Background |
Neuron-Specific
Enolase (NSE) is recognized as a biomarker for small cell lung cancer. It is
secreted from neuroendocrine cells as well as neurogenic tumors. Its levels in
NSE-secreting neoplasms correlate with tumor mass and tumor metabolic activity. |
